Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

被引：0
|
作者：
Hakon Blomstrand
Ursula Scheibling
Charlotte Bratthäll
Henrik Green
Nils O. Elander
机构：
[1] Ryhov County Hospital,Department of Oncology
[2] Linköping University,Division of Oncology, Department of clinical and experimental medicine, Faculty of medicine and health sciences
[3] Kalmar County Hospital,Department of Oncology
[4] Linköping University,Division of Drug Research, Department of Medical Health Sciences
[5] Department of Forensic Genetics and Forensic Toxicology,undefined
[6] National Board of Forensic Medicine,undefined
来源：
BMC Cancer | / 19卷
关键词：
Pancreatic cancer; Chemotherapy; Gemcitabine; Nab-paclitaxel; Bone marrow toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Gemcitabine (G) and nab-paclitaxel (nab-P) in patients with refractory advanced pancreatic cancer (PC).
    Ernani, Vinicius
    Akunyili, Ikechukwu Immanuel
    Hosein, Peter Joel
    Macintyre, Jessica
    Lima, Caio Max S. Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [42] Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
    Picozzi, Vincent
    Alseidi, Adnan
    Winter, Jordan
    Pishvaian, Michael
    Mody, Kabir
    Glaspy, John
    Larson, Timothy
    Matrana, Marc
    Carney, Mairead
    Porter, Seth
    Kouchakji, Elias
    Rocha, Flavio
    Carrier, Ewa
    ESMO OPEN, 2020, 5 (04)
  • [43] Gemcitabine plus nab-paclitaxel as first-line chemotherapy for Japanese patients with advanced pancreatic cancer in real-world clinical practice: a retrospective study
    Yamaguchi, T.
    Ueno, H.
    Sasaki, M.
    Sakamoto, Y.
    Kondo, S.
    Morizane, C.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2016, 27 : 35 - 35
  • [44] FOLFIRINOX for Advanced Pancreatic Cancer Patients After Nab-Paclitaxel Plus Gemcitabine Failure
    Matsumoto, Toshihiko
    Kurioka, Yusuke
    Okazaki, Ukyo
    Matsuo, Yu
    Kimura, Shogo
    Miura, Kou
    Tsuduki, Takao
    Takagi, Shinjiro
    Takatani, Masahiro
    Morishita, Hirofumi
    PANCREAS, 2020, 49 (04) : 574 - 578
  • [45] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Junko Tahara
    Kyoko Shimizu
    Nao Otsuka
    Junichi Akao
    Yukiko Takayama
    Katsutoshi Tokushige
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 245 - 250
  • [46] Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer
    Perez, Kimberly
    Weekes, Colin D.
    Cleary, James M.
    Abrams, Thomas Adam
    Blaszkowsky, Lawrence Scott
    Enzinger, Peter C.
    Giannakis, Marios
    Goyal, Lipika
    Meyerhardt, Jeffrey A.
    Rubinson, Douglas Adam
    Yurgelun, Matthew B.
    Stonely, Danielle
    Raghavan, Srivatsan
    Bakir, Basil
    Das, Koushik
    Pitarresi, Jason
    Aguirre, Andrew
    Needle, Michael N.
    Rustgi, Anil
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [47] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [48] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [49] Effect of Preoperative Nab-paclitaxel and Gemcitabine on Pancreatic Cancer Stroma
    Ishido, K.
    Kimura, N.
    Wakiya, T.
    Nagase, H.
    Odagiri, T.
    Mitsuhashi, Y.
    Goto, S.
    Yoshizawa, T.
    Kijima, H.
    Hakamada, K.
    PANCREAS, 2019, 48 (10) : 1451 - 1451
  • [50] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Tahara, Junko
    Shimizu, Kyoko
    Otsuka, Nao
    Akao, Junichi
    Takayama, Yukiko
    Tokushige, Katsutoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
12345